Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What's Going On With Novavax Stock?

TheMotleyFool

0 0

Shares of Novavax (NASDAQ: NVAX) have been extremely volatile as the market tries to value the company's COVID-19 vaccine. In January of last year, the company's stock was valued at $4 a share. The stock zoomed higher when COVID-19 hit, the tiny company introduced its vaccine candidate, and saw early success in clinical trials. After the biotech reported positive phase 3 data earlier this year, the stock hit $330 a share.

Since then the stock has crashed about 60%, falling to a recent price of $134 as of this writing. Why has the stock been so volatile, and where will it go next? Let's dig in.

Image source: Getty Images

Source Fool.com

Like: 0

NVAX

Share